ArticleScientific reports2022

Claudin-3 inhibits tumor-induced lymphangiogenesis via regulating the PI3K signaling pathway in lymphatic endothelial cells.

Ningjing Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.